» Articles » PMID: 33748100

10-Gingerol Suppresses Osteoclastogenesis in RAW264.7 Cells and Zebrafish Osteoporotic Scales

Overview
Specialty Cell Biology
Date 2021 Mar 22
PMID 33748100
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoporosis is the most common aging-associated bone disease and is caused by hyperactivation of osteoclastic activity. We previously reported that the hexane extract of ginger rhizome [ginger hexane extract (GHE)] could suppress receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclastogenesis in RAW264.7 cells. However, the anti-osteoclastic components in GHE have not yet been identified. In this study, we separated GHE into several fractions using silica gel column chromatography and evaluated their effects on osteoclastogenesis using a RAW264.7 cell osteoclast differentiation assay () and the zebrafish scale model of osteoporosis (). We identified that the fractions containing 10-gingerol suppressed osteoclastogenesis in RAW264.7 cells detected by tartrate-resistant acid phosphatase (TRAP) staining. In zebrafish, GHE and 10-gingerol suppressed osteoclastogenesis in prednisolone-induced osteoporosis regenerated scales to promote normal regeneration. Gene expression analysis revealed that 10-gingerol suppressed osteoclast markers in RAW264.7 cells [osteoclast-associated immunoglobulin-like receptor, dendrocyte-expressed seven transmembrane protein, and matrix metallopeptidase-9 ()] and zebrafish scales [osteoclast-specific cathepsin K (CTSK), , and ]. Interestingly, nuclear factor of activated T-cells cytoplasmic 1, a master transcription regulator of osteoclast differentiation upstream of the osteoclastic activators, was downregulated in zebrafish scales but showed no alteration in RAW264.7 cells. In addition, 10-gingerol inhibited CTSK activity under cell-free conditions. This is the first study, to our knowledge, that has found that 10-gingerol in GHE could suppress osteoclastic activity in both and conditions.

Citing Articles

Osteoporosis: Causes, Mechanisms, Treatment and Prevention: Role of Dietary Compounds.

Stromsnes K, Martinez Fajardo C, Soto-Rodriguez S, Kajander E, Lupu R, Pozo-Rodriguez M Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770539 PMC: 11679375. DOI: 10.3390/ph17121697.


Bioactive Compounds in Osteoarthritis: Molecular Mechanisms and Therapeutic Roles.

Maouche A, Boumediene K, Bauge C Int J Mol Sci. 2024; 25(21).

PMID: 39519204 PMC: 11546619. DOI: 10.3390/ijms252111656.


Gingerol-zinc complex loaded 3D-printed calcium phosphate for controlled release application.

Chaudhari V, White B, Dahiya A, Bose S Drug Deliv Transl Res. 2024; 15(4):1317-1329.

PMID: 39179707 DOI: 10.1007/s13346-024-01677-9.


A zebrafish model of diabetic nephropathy shows hyperglycemia, proteinuria and activation of the PI3K/Akt pathway.

Zang L, Saitoh S, Katayama K, Zhou W, Nishimura N, Shimada Y Dis Model Mech. 2024; 17(5).

PMID: 38747698 PMC: 11152558. DOI: 10.1242/dmm.050438.


A mechanistic review of chinese medicine polyphenols on bone formation and resorption.

Li Y, Li L, Li X, Luo B, Ye Q, Wang H Front Pharmacol. 2022; 13:1017538.

PMID: 36313339 PMC: 9597080. DOI: 10.3389/fphar.2022.1017538.


References
1.
Drake M, Clarke B, Khosla S . Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc. 2008; 83(9):1032-45. PMC: 2667901. DOI: 10.4065/83.9.1032. View

2.
Sire J, Allizard F, Babiar O, Bourguignon J, Quilhac A . Scale development in zebrafish (Danio rerio). J Anat. 1997; 190 ( Pt 4):545-61. PMC: 1467640. DOI: 10.1046/j.1469-7580.1997.19040545.x. View

3.
Tat S, Pelletier J, Mineau F, Caron J, Martel-Pelletier J . Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts. Bone. 2011; 49(3):559-67. DOI: 10.1016/j.bone.2011.06.005. View

4.
Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J . Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos. 2013; 8:137. PMC: 3880492. DOI: 10.1007/s11657-013-0137-0. View

5.
Yeh I, Chen S, Yen M, Wu Y, Hung C, Kuo P . 6-Shogaol Suppresses 2-Amino-1-Methyl-6-Phenylimidazo [4,5-b] Pyridine (PhIP)-Induced Human 786-O Renal Cell Carcinoma Osteoclastogenic Activity and Metastatic Potential. Nutrients. 2019; 11(10). PMC: 6835604. DOI: 10.3390/nu11102306. View